{"id":12165,"date":"2021-01-18T14:30:01","date_gmt":"2021-01-18T12:30:01","guid":{"rendered":"http:\/\/www.edarges.ro\/www\/?p=12165"},"modified":"2021-02-01T14:31:20","modified_gmt":"2021-02-01T12:31:20","slug":"comisia-prezinta-o-strategie-farmaceutica-pentru-europa","status":"publish","type":"post","link":"https:\/\/www.edarges.ro\/www\/?p=12165","title":{"rendered":"Comisia prezint\u0103 o Strategie farmaceutic\u0103 pentru Europa"},"content":{"rendered":"<p style=\"font-weight: 400; text-align: justify;\">Comisia a adoptat o <a href=\"https:\/\/ec.europa.eu\/health\/human-use\/strategy_ro\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/ec.europa.eu\/health\/human-use\/strategy_ro&amp;source=gmail&amp;ust=1612268402907000&amp;usg=AFQjCNF43UKrKivaz5zVaKyfNqnAlpGXFg\"><u>Strategie farmaceutic\u0103 pentru Europa<\/u><\/a>\u00a0viz\u00e2nd asigurarea disponibilit\u0103\u021bii pentru pacien\u021bi a unor medicamente inovatoare \u0219i accesibile financiar, precum \u0219i sprijinirea competitivit\u0103\u021bii, a capacit\u0103\u021bii de inovare \u0219i a sustenabilit\u0103\u021bii industriei farmaceutice din UE.<\/p>\n<p style=\"font-weight: 400; text-align: justify;\">Strategia farmaceutic\u0103 pentru Europa are patru obiective principale:<\/p>\n<ul style=\"font-weight: 400; text-align: justify;\">\n<li>Asigurarea\u00a0<strong>disponibilit\u0103\u021bii<\/strong>\u00a0pentru pacien\u021bi a unor\u00a0<strong>medicamente accesibile financiar<\/strong>\u00a0\u0219i abordarea nevoilor medicale nesatisf\u0103cute (de exemplu, \u00een domeniul rezisten\u021bei la antimicrobiene, al cancerului, al bolilor rare);<\/li>\n<li>Sprijinirea\u00a0<strong>competitivit\u0103\u021bii, a inov\u0103rii \u0219i a sustenabilit\u0103\u021bii<\/strong>\u00a0industriei farmaceutice din\u00a0UE \u0219i crearea unor medicamente de \u00eenalt\u0103 calitate, sigure, eficace \u0219i mai ecologice;<\/li>\n<li>\u00cembun\u0103t\u0103\u021birea mecanismelor de\u00a0<strong>preg\u0103tire \u0219i r\u0103spuns la crize<\/strong>\u00a0\u0219i abordarea securit\u0103\u021bii aprovizion\u0103rii;<\/li>\n<li>Asigurarea unei\u00a0<strong>voci puternice a UE pe plan mondial<\/strong>, prin promovarea\u00a0unui nivel \u00eenalt al standardelor \u00een materie de calitate, eficacitate \u0219i siguran\u021b\u0103.<\/li>\n<\/ul>\n<p style=\"font-weight: 400; text-align: justify;\">Mai multe informa\u0163ii \u00een\u00a0<a href=\"https:\/\/ec.europa.eu\/romania\/news\/20201125_strategie_farmaceutica_pentru_europa_ro\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/ec.europa.eu\/romania\/news\/20201125_strategie_farmaceutica_pentru_europa_ro&amp;source=gmail&amp;ust=1612268402907000&amp;usg=AFQjCNH8dPWJiMNxn1p5fVWkSjf1Bj_TyA\"><u>comunicatul de pres\u0103<\/u><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Comisia a adoptat o Strategie farmaceutic\u0103 pentru Europa\u00a0viz\u00e2nd asigurarea disponibilit\u0103\u021bii pentru pacien\u021bi a unor medicamente inovatoare \u0219i accesibile financiar, precum \u0219i sprijinirea competitivit\u0103\u021bii, a capacit\u0103\u021bii de inovare \u0219i a sustenabilit\u0103\u021bii industriei farmaceutice din UE. Strategia farmaceutic\u0103 pentru Europa are patru obiective principale: Asigurarea\u00a0disponibilit\u0103\u021bii\u00a0pentru pacien\u021bi a unor\u00a0medicamente accesibile financiar\u00a0\u0219i abordarea nevoilor medicale nesatisf\u0103cute (de exemplu, \u00een &hellip; <a href=\"https:\/\/www.edarges.ro\/www\/?p=12165\">Continued<\/a><\/p>\n","protected":false},"author":3,"featured_media":11147,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[17],"tags":[],"_links":{"self":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts\/12165"}],"collection":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12165"}],"version-history":[{"count":1,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts\/12165\/revisions"}],"predecessor-version":[{"id":12166,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/posts\/12165\/revisions\/12166"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=\/wp\/v2\/media\/11147"}],"wp:attachment":[{"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12165"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12165"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.edarges.ro\/www\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}